San Diego-primarily based Viking Therapeutics marked alone as a significant competitor while in the weight loss drug industry in February right after revealing promising details from a mid-stage trial of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when given as a weekly injection As well as in Marc